NEUROPHYSIOLOGY OF THE HYPOTHYROID OVINE FETUS

甲状腺功能减退症绵羊胎儿的神经生理学

基本信息

  • 批准号:
    3319780
  • 负责人:
  • 金额:
    $ 7.98万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    1986
  • 资助国家:
    美国
  • 起止时间:
    1986-09-01 至 1989-08-31
  • 项目状态:
    已结题

项目摘要

Central nervous system (CNS) dysfunction continues to be a problem in infants with congenital primary hypothyroidism in spite of the advances made to allow early diagnosis and treatment through neonatal screening programs. Many of these CNS abnormalities may be due to the effect of hypothyroidism in intrauterine life. The long term objective of this study is to determine the effect of fetal thyroidectomy on some markers of brain maturation and function using the ovine fetus as the experimental model. The specific aims of the study are to prove that (1) thyroidectomy in the ovine fetus causes significant delay in the maturational pattern of the neurotransmitters norepinephrine (NE), dopamine (DA), and serotonin (5HT) in specific brain areas, and auditory and somatosensory evoked responses (ER). (2) Replacement therapy with thyroid hormones allows the normal maturational progress of NE, DA 5HT and ER in these areas to resume. (3) If therapy is delayed past a "critical time period," the normal maturation of NE, DA, 5HT and ER is permanently arrested. (4) The changes in NE, DA and 5HT caused by ovine fetal thyroidectomy cause plasma concentrations of growth hormone (GH) and prolactin (PRL) to be unresponsive to the NE receptor agonist clonidine the DA receptor agonist apomorphine, and the 5HT precursor 5 hydroxytryptophan (5HTP). To achieve these aims, ovine fetuses will undergo thyroidectomy at 85 days gestation. Control fetuses will undergo sham thyroidectomy. To accomplish Aim 1: NE, DA and 5HT in cerebrospinal fluid (CSF) and EF will be measured at set intervals in thyroidectomy and control fetuses. NE, DA and 5HT will also be measured in specific brain areas at the conclusion of the experiment. Aim 2: thyroid hormone replacement therapy will be given to thyroidectomized fetuses beginning at different intervals after thyroidectomy NE, DA and 5HT in CSF and ER will be measured at set intervals for the remainder of gestation. At the conclusion of the experiment, NE, DA and 5HT will be measured in specific brain areas. Aim 3: thyroidectomized fetuses will be studied at more frequent intervals for a limited segment of gestation with measurement of NE, DA and 5HT in CSF and in specific brain areas at the end of the experiment. Aim 4: the response of plasma GH and PRL to clonidine, apomorphine and 5HTP in thyroidectomized and control fetuses will be tested. The results of this study will more clearly define the mechanism by which hypothyroidism interferes with CNS function during fetal development.
中枢神经系统(CNS)功能障碍仍然是一个问题

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

GAIL E RICHARDS其他文献

GAIL E RICHARDS的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('GAIL E RICHARDS', 18)}}的其他基金

A PARALLEL GROUP STUDY OF SAFETY AND EFFICACY OF THE LB03002 A NEW SUSTAINED
LB03002 的安全性和有效性的平行小组研究
  • 批准号:
    7603566
  • 财政年份:
    2007
  • 资助金额:
    $ 7.98万
  • 项目类别:
NEUROPHYSIOLOGY OF THE HYPOTHYROID OVINE FETUS
甲状腺功能减退症绵羊胎儿的神经生理学
  • 批准号:
    3319782
  • 财政年份:
    1986
  • 资助金额:
    $ 7.98万
  • 项目类别:
NEUROPHYSIOLOGY OF THE HYPOTHYROID OVINE FETUS
甲状腺功能减退症绵羊胎儿的神经生理学
  • 批准号:
    3319777
  • 财政年份:
    1986
  • 资助金额:
    $ 7.98万
  • 项目类别:
NEUROPHYSIOLOGY OF THE HYPOTHYROID OVINE FETUS
甲状腺功能减退症绵羊胎儿的神经生理学
  • 批准号:
    3319781
  • 财政年份:
    1986
  • 资助金额:
    $ 7.98万
  • 项目类别:
NEUROTRANSMITTER REGULATION OF GROWTH HORMONE SECRETION
生长激素分泌的神经递质调节
  • 批准号:
    3884391
  • 财政年份:
  • 资助金额:
    $ 7.98万
  • 项目类别:
NEUROTRANSMITTER REGULATION OF GROWTH HORMONE SECRETION
生长激素分泌的神经递质调节
  • 批准号:
    4700264
  • 财政年份:
  • 资助金额:
    $ 7.98万
  • 项目类别:
DIAGNOSITC USE OF LUTEINIZING HORMONE RELEASING HORMONE IN CHILDREN
儿童黄体生成激素释放激素的诊断用途
  • 批准号:
    4700235
  • 财政年份:
  • 资助金额:
    $ 7.98万
  • 项目类别:
CONGENITAL PRIMARY HYPOTHYROIDISM--BRAIN DEVELOPMENT INDICES
先天性原发性甲状腺功能减退症--大脑发育指数
  • 批准号:
    4700249
  • 财政年份:
  • 资助金额:
    $ 7.98万
  • 项目类别:

相似国自然基金

基于多巴胺受体D2亚型为靶标的结构新颖的Apomorphine衍生物的合成及生物活性评估
  • 批准号:
    30672517
  • 批准年份:
    2006
  • 资助金额:
    30.0 万元
  • 项目类别:
    面上项目

相似海外基金

Impairment of insulin signaling in Alzheimer's disease and combined therapy with apomorphine and insulin
阿尔茨海默病中胰岛素信号传导受损以及阿扑吗啡和胰岛素联合治疗
  • 批准号:
    17K09302
  • 财政年份:
    2017
  • 资助金额:
    $ 7.98万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Development of apomorphine therapy targeting insulin resistance in Alzheimer's disease
针对阿尔茨海默病胰岛素抵抗的阿扑吗啡疗法的开发
  • 批准号:
    26461274
  • 财政年份:
    2014
  • 资助金额:
    $ 7.98万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Molecular mechanism of apomorphine therapy for Alzheimer disease
阿朴吗啡治疗阿尔茨海默病的分子机制
  • 批准号:
    23890150
  • 财政年份:
    2011
  • 资助金额:
    $ 7.98万
  • 项目类别:
    Grant-in-Aid for Research Activity Start-up
Apomorphine-induced modulation of neural activities in the ventrolateral striatum of rat
阿朴吗啡诱导的大鼠腹外侧纹状体神经活动的调节
  • 批准号:
    22792127
  • 财政年份:
    2010
  • 资助金额:
    $ 7.98万
  • 项目类别:
    Grant-in-Aid for Young Scientists (B)
Development of apomorphine therapy for Alzheimer disease
阿朴吗啡治疗阿尔茨海默病的进展
  • 批准号:
    22590936
  • 财政年份:
    2010
  • 资助金额:
    $ 7.98万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
CAN APOMORPHINE PRODUCE A LONG DURATION RESPONSE
阿扑吗啡可以产生长时间的反应吗
  • 批准号:
    6465837
  • 财政年份:
    2000
  • 资助金额:
    $ 7.98万
  • 项目类别:
APOMORPHINE CHALLENGE IN SCHIZOPHRENIA & NORMALS
阿扑吗啡对精神分裂症的挑战
  • 批准号:
    6305710
  • 财政年份:
    1999
  • 资助金额:
    $ 7.98万
  • 项目类别:
APOMORPHINE CHALLENGE IN SCHIZOPHRENIA & NORMALS
阿扑吗啡对精神分裂症的挑战
  • 批准号:
    6264575
  • 财政年份:
    1998
  • 资助金额:
    $ 7.98万
  • 项目类别:
CAN APOMORPHINE PRODUCE A LONG DURATION RESPONSE
阿扑吗啡可以产生长时间的反应吗
  • 批准号:
    6116979
  • 财政年份:
    1998
  • 资助金额:
    $ 7.98万
  • 项目类别:
SUBLINGUAL APOMORPHINE IN PARKINSON'S DISEASE--TOLERABILITY AND EFFICACY
舌下含服阿扑吗啡治疗帕金森病——耐受性和疗效
  • 批准号:
    6116967
  • 财政年份:
    1998
  • 资助金额:
    $ 7.98万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了